NAC (N-acetylcysteine): the evidence, from antidote to supplement

N-acetylcysteine, almost always shortened to NAC, is a modified form of the amino acid cysteine and the body's most efficient way to top up glutathione, its master antioxidant. That single mechanism explains both its life-saving role as the hospital antidote for paracetamol overdose and the long list of hopeful claims now attached to it as a supplement. The honest picture is sharply tiered, and in the UK there is an added twist, because NAC is a licensed medicine, not merely a supplement.

What NAC is, and the glutathione idea

NAC is cysteine with a small acetyl group attached, which makes it more stable and better absorbed. Inside cells it converts back to cysteine, the rate-limiting building block for glutathione, the body's most important internal antioxidant.¹² Glutathione neutralises reactive molecules and helps the liver process toxins, so anything that reliably refills it has real biochemical clout. NAC also acts more directly: it breaks disulphide bonds, which is how it thins mucus. This is the engine room behind every NAC claim. The useful question, addressed below, is where topping up glutathione actually changes an outcome that matters, and where it merely sounds as though it should. For how single ingredients fit a wider plan, see our health library.

The gold standard: paracetamol overdose

This is NAC at its most impressive, and it is a licensed medicine, not a supplement use. A paracetamol (acetaminophen) overdose generates a toxic metabolite that the liver normally detoxifies with glutathione; in overdose, glutathione is overwhelmed and liver cells die. Intravenous acetylcysteine refills cysteine and therefore glutathione, neutralising the metabolite before it does harm.¹ Given early it is close to 100% effective at preventing serious liver injury, and it has been the standard UK treatment for over four decades. The MHRA-authorised regimen delivers 300 mg/kg over roughly 21 hours, with simplified protocols now used to cut the nausea and flushing the older schedule often caused.¹ The lay takeaway is blunt: a paracetamol overdose is an emergency and the antidote works best in the first 8 hours, so call 999 or 111 at once rather than waiting for symptoms.

Mucolytic for COPD and cystic fibrosis

NAC's mucus-thinning action makes it a mucolytic, and this is also a licensed medicine in the UK: an oral effervescent preparation (NACSYS 600 mg) was licensed in 2017 for respiratory disorders including chronic bronchitis, emphysema, bronchiectasis and cystic fibrosis.² The trial evidence is genuine but modest. A 2019 Cochrane review pooled 38 studies and 10,377 people on mucolytics, finding they raised the odds of staying free of a flare-up (odds ratio 1.73, 95% confidence interval 1.56 to 1.91), with about 8 people needing treatment for nine months to keep one extra person exacerbation-free.³ The largest single NAC trial, PANTHEON, randomised roughly 1,000 Chinese patients with moderate-to-severe COPD to 600 mg twice daily or placebo for a year and reported about a fifth fewer exacerbations.⁴ The caveats matter: the benefit is on flare-up frequency, not lung function or survival, and NAC is an add-on, never a replacement for inhalers, vaccination or stopping smoking. In cystic fibrosis the data are genuinely mixed and NAC is not a core therapy.

Reasonable evidence: the psychiatric add-on

The most interesting off-label story is in psychiatry, where NAC is studied as an add-on alongside standard treatment, not a stand-alone drug, on the theory that it modulates glutamate, a brain signalling chemical tied to compulsive behaviour. The clearest result is in adult trichotillomania (compulsive hair-pulling): a 2009 double-blind trial of 50 adults found 1200 to 2400 mg/day produced significant improvement in 56% of the NAC group versus 16% on placebo.⁵ Encouraging, but not universal: a later trial in children found no benefit, a reminder that an adult result does not automatically transfer.⁶

For obsessive-compulsive disorder (OCD), a 2012 trial in 48 adults with treatment-resistant OCD found 52.6% became full responders on NAC versus 15% on placebo.⁷ But a 2024 meta-analysis of six randomised trials judged the effect inconsistent, mainly visible in a narrow window around weeks five to eight, which is why NAC is not in OCD guidelines.⁸ Skin-picking shows the same pattern of modest, mixed adult evidence. The fair summary: NAC is a low-risk, genuinely researched adjunct here, but it is unlicensed and off-label, the effect is modest, and it should sit alongside first-line care such as specialist therapy and prescribed medication, never replace it. See our guide to intrusive thoughts and OCD for the proven treatments.

The heavily marketed, weaker claims

This is where ambition outruns evidence. The supplement industry leans on the glutathione story to sell NAC for fertility, liver health, detox and longevity. The biology is plausible in each case, but plausibility is not proof.

Fertility. A 2021 meta-analysis in men with unexplained infertility found NAC improved semen markers such as sperm concentration and motility.¹⁰ The catch is that these are surrogate measures: the trials do not show NAC increases actual pregnancies or live births. In polycystic ovary syndrome small trials suggest it may modestly improve ovulation versus placebo, but it appears inferior to metformin and is not standard care. Treat any fertility use as experimental and off-label.

Fatty liver. A 2023 meta-analysis found NAC can modestly lower ALT, a liver enzyme, in fatty liver disease (now termed MASLD).⁹ But a lower enzyme is not a healthier liver on scan, the trials are small and short, and nothing here displaces the proven lever, weight loss. Our guide to fatty liver disease (MASLD) sets out what actually reverses it.

Detox and longevity. The cleanest cautionary tale is contrast-induced kidney injury: the antioxidant rationale was strong, yet the large PRESERVE trial of over 5,000 patients (2018) found NAC no better than placebo (4.6% versus 4.5%).¹¹ That is the pattern to remember. For general detox there is no human trial showing NAC cleanses an otherwise healthy body, and for longevity no randomised human evidence that it extends lifespan. Pressure-test claims like these with our insights approach and the stack builder.

The UK regulatory nuance

Here the UK and US diverge in a way that confuses shoppers. In the UK, acetylcysteine is firmly a licensed medicine: as the intravenous antidote, as the oral effervescent mucolytic (NACSYS), and as acetylcysteine eye drops.¹² It is also sold as a food supplement. UK borderline-product rules mean anything making a medicinal claim is treated as a medicine and needs a licence, so a NAC product is judged partly by what it claims to do.

The availability wobble many people noticed traces mainly to the US. There, the FDA argued that because NAC was approved as a drug in 1963, before it was sold as a supplement, it is technically excluded from the supplement category. After warning letters, Amazon delisted NAC supplements in 2021, which rippled into UK marketplaces, before the FDA announced enforcement discretion in 2022, effectively letting sales continue.¹² The takeaway: NAC's on-and-off shelf presence has been a regulatory and classification story, not a safety verdict. Supplement-grade NAC is also not quality-controlled to medicine standards, so potency and purity vary between brands.

Dosing, safety and interactions

Supplement doses cluster at 600 to 1800 mg/day, often 600 mg once to three times daily; psychiatric and liver trials ran higher, to 2400 or 3000 mg/day.⁷ Oral NAC is generally well tolerated, the commonest complaints being gastrointestinal (nausea, diarrhoea) and a sulphurous smell. The intravenous form can trigger anaphylactoid reactions (flushing, rash, wheeze), managed in hospital and not a feature of normal oral doses.

The bottom line

NAC is two very different things wearing one name. As a licensed medicine it is genuinely excellent: a life-saving antidote and a respectable mucolytic, both resting on solid evidence. As a supplement it is a plausible, low-risk experiment with a few areas of modest support (compulsive hair-pulling and skin-picking, perhaps OCD as an adjunct) and a much larger zone of marketing the human trials do not yet justify (fertility outcomes, reversing fatty liver, detox, longevity). If you try it, be clear which story you are buying into, keep the dose in the studied range, tell your GP and pharmacist, and judge it on an honest before-and-after. New to changing one thing at a time? Start with our getting-started guide.

This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.